{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:44:19Z","timestamp":1793907859192,"version":"4.8.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Rheumatoid arthritis (RA) is associated with increased cardiovascular (CV) risk, yet the mechanisms remain unclear. This study aimed to evaluate myocardial structure, function, and tissue characterization using cardiovascular magnetic resonance (CMR) in RA patients and explore associations with RA disease severity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This mixed case-control study included 48 RA patients and 34 age- and sex-matched controls. RA patients were enrolled based on ACR\/EULAR criteria, excluding other autoimmune diseases or significant coronary artery calcification. CMR assessed myocardial structure, function, and tissue characteristics, including native T1\/T2 mapping, ventricular volumes, strain analysis, and late gadolinium enhancement. Linear regression models adjusted for age, sex, hypertension, and diabetes evaluated associations between RA characteristics and CMR parameters.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>RA patients exhibited elevated native T1 values (980\u2009\u00b1\u200934\u2005ms vs. 955\u2009\u00b1\u200933\u2005ms; <jats:italic>P<\/jats:italic>\u2009&amp;lt;\u20090.01), indicative of subclinical myocardial fibrosis. Left ventricular global longitudinal strain (GLS) was reduced (22\u2009\u00b1\u20092% vs. 24\u2009\u00b1\u20093%; <jats:italic>P<\/jats:italic>\u2009&amp;lt;\u20090.01), and increased left ventricular mass and remodeling were observed. Right ventricular end-diastolic and end-systolic volume indices were lower in RA patients (RVEDVi: 68\u2009\u00b1\u200914\u2005ml\/m<jats:sup>2<\/jats:sup> vs. 75\u2009\u00b1\u200912\u2005ml\/m<jats:sup>2<\/jats:sup>, <jats:italic>P<\/jats:italic>\u2009=\u20090.02). Disease duration correlated negatively with GLS (<jats:italic>\u03b2<\/jats:italic>\u2009=\u2009\u22120.06, <jats:italic>P<\/jats:italic>\u2009&amp;lt;\u20090.05), while higher DAS28 scores were linked to reduced ejection fraction (<jats:italic>\u03b2<\/jats:italic>\u2009=\u2009\u22124.11, <jats:italic>P<\/jats:italic>\u2009&amp;lt;\u20090.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study demonstrates significant myocardial alterations in RA patients, including fibrosis, impaired systolic function, and ventricular remodeling, linked to disease severity. These findings highlight the need for early CV risk assessment and inflammation control to mitigate CV complications in RA.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2025.1607018","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T05:28:43Z","timestamp":1755754123000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Subclinical myocardial changes in rheumatoid arthritis: cardiovascular magnetic resonance evidence of immuno-inflammatory remodeling"],"prefix":"10.3389","volume":"12","author":[{"given":"Zoltan","family":"Tarjanyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoletta","family":"Mong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsofia","family":"Dohy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsofia Dora","family":"Drobni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexisz","family":"Panajotu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laszlo","family":"Tothfalusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Szappanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Raisi-Estabragh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bela","family":"Merkely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyorgy","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajnalka","family":"Vago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.1186\/ar578","article-title":"Epidemiology and genetics of rheumatoid arthritis","volume":"4","author":"Silman","year":"2002","journal-title":"Arthritis Res"},{"key":"B2","first-page":"286","article-title":"Extra-articular manifestations in rheumatoid arthritis","volume":"5","author":"Cojocaru","year":"2010","journal-title":"Maedica (Bucur)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41584-019-0170-5","article-title":"Treat-to-target in rheumatoid arthritis \u2014 are we there yet?","volume":"15","author":"van Vollenhoven","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.3390\/cells10112857","article-title":"Management of rheumatoid arthritis: an overview","volume":"10","author":"Radu","year":"2021","journal-title":"Cells"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/annrheumdis-2020-217344","article-title":"EULAR definition of difficult-to-treat rheumatoid arthritis","volume":"80","author":"Nagy","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B7","first-page":"40","article-title":"The disease activity score (DAS) and the disease activity score using 28 joint counts (DAS28) in the management of rheumatoid arthritis","volume":"34","author":"Riel","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3390\/ijms22020686","article-title":"From rheumatoid factor to anti-citrullinated protein antibodies and anti-carbamylated protein antibodies for diagnosis and prognosis prediction in patients with rheumatoid arthritis","volume":"22","author":"Wu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00281-017-0632-2","article-title":"Cardiovascular risk in patients with rheumatoid arthritis","volume":"39","author":"Lauper","year":"2017","journal-title":"Semin Immunopathol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tcm.2016.07.006","article-title":"Cardiovascular disease in patients with rheumatoid arthritis","volume":"27","author":"Liao","year":"2017","journal-title":"Trends Cardiovasc Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"R131","DOI":"10.1186\/ar3442","article-title":"Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study","volume":"13","author":"Innala","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"B12","doi-asserted-by":"publisher","first-page":"523962","DOI":"10.3389\/fphar.2020.601344","article-title":"Largely accelerated arterial aging in rheumatoid arthritis is associated with inflammatory activity and smoking in the early stage of the disease","volume":"11","author":"Mong","year":"2020","journal-title":"Front Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1093\/rheumatology\/keac584","article-title":"Comorbidities and extra-articular manifestations in difficult-to-treat rheumatoid arthritis: different sides of the same coin?","volume":"62","author":"Dey","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/art.1780370408","article-title":"The mortality of rheumatoid arthritis","volume":"37","author":"Wolfe","year":"1994","journal-title":"Arthritis Rheum"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"59","author":"Avi\u00f1a-Zubieta","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","article-title":"Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"71","author":"Avina-Zubieta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jacc.2013.05.016","article-title":"High-sensitivity C-reactive protein and cardiovascular disease","volume":"62","author":"Yousuf","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B18","first-page":"937","article-title":"Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis","volume":"34","author":"Aubry","year":"2007","journal-title":"J Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/art.41122","article-title":"Impact of cumulative inflammation, cardiac risk factors, and medication exposure on coronary atherosclerosis progression in rheumatoid arthritis","volume":"72","author":"Karpouzas","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1093\/rheumatology\/keu224","article-title":"Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment","volume":"53","author":"Choy","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1093\/eurheartj\/ehw208","article-title":"Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis","volume":"38","author":"Lazzerini","year":"2017","journal-title":"Eur Heart J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jcmg.2014.12.025","article-title":"Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 mapping","volume":"8","author":"Ntusi","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"B23","doi-asserted-by":"publisher","first-page":"R171","DOI":"10.1186\/ar3131","article-title":"Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study","volume":"12","author":"Kobayashi","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"B24","first-page":"416","article-title":"Cardiac magnetic resonance imaging reveals frequent myocardial involvement and dysfunction in active rheumatoid arthritis","volume":"34","author":"Holmstr\u00f6m","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1002\/acr.23138","article-title":"Magnetic resonance imaging-detected myocardial inflammation and fibrosis in rheumatoid arthritis: associations with disease characteristics and N-terminal pro-brain natriuretic peptide levels","volume":"69","author":"Kobayashi","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3899\/jrheum.170770","article-title":"Absence of fibrosis and inflammation by cardiac magnetic resonance imaging in rheumatoid arthritis patients with low to moderate disease activity","volume":"45","author":"Bradham","year":"2018","journal-title":"J Rheumatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1161\/HYPERTENSIONAHA.111.198028","article-title":"Left ventricular global function index by magnetic resonance imaging\u2013a novel marker for assessment of cardiac performance for the prediction of cardiovascular events: the multi-ethnic study of atherosclerosis","volume":"61","author":"Mewton","year":"2013","journal-title":"Hypertension"},{"key":"B29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12968-020-00610-6","article-title":"Standardized image interpretation and post-processing in cardiovascular magnetic resonance\u20142020 update","volume":"22","author":"Schulz-Menger","year":"2025","journal-title":"J Cardiovasc Magn Reson"},{"key":"B30","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jcmg.2024.07.011","article-title":"Myocardial strain imaging: theory, current practice, and the future","volume":"18","author":"Smiseth","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"key":"B31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s10238-023-01288-7","article-title":"Stroke risk in rheumatoid arthritis patients: exploring connections and implications for patient care","volume":"24","author":"Al-Ewaidat","year":"2024","journal-title":"Clin Exp Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jacc.2021.11.050","article-title":"Myocardial fibrosis predicts ventricular arrhythmias and sudden death after cardiac electronic device implantation","volume":"79","author":"Leyva","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of heart failure","volume":"22","author":"Groenewegen","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of disease study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1002\/art.21349","article-title":"How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?","volume":"52","author":"Crowson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B36","doi-asserted-by":"publisher","first-page":"42:ehab724.0774","DOI":"10.1093\/eurheartj\/ehab724.0774","article-title":"Risk factors for early concentric left ventricular remodelling in women and men at risk for heart failure","volume":"42","author":"Van Ommen","year":"2021","journal-title":"Eur Heart J"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.669335","article-title":"Left ventricular remodeling and myocardial work: results from the population-based STAAB cohort study","volume":"8","author":"Sahiti","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.3390\/jcm10214980","article-title":"Cardiac MRI based left ventricular global function Index: association with disease severity in patients with ICD for secondary prevention","volume":"10","author":"Schober","year":"2021","journal-title":"J Clin Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"751907","DOI":"10.3389\/fcvm.2021.751907","article-title":"Association between left ventricular global function Index and outcomes in patients with dilated cardiomyopathy","volume":"8","author":"Liu","year":"2021","journal-title":"Front Cardiovasc Med"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1607018\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T05:28:44Z","timestamp":1755754124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1607018\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":39,"alternative-id":["10.3389\/fcvm.2025.1607018"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1607018","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"article-number":"1607018"}}